ESR1 and breast carcinoma: Contrary to the expression of miR-190 as determined by RT-qPCR (Fig. 1a), western blot analysis revealed that the expression of SOX9 was much higher in ER− breast cancer cell lines compared with that in the ER+ breast cancer cell lines (Fig. 3c).